Suzhou Basecare Medical Corporation Limited (02170.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 1.38

From 52W high−59.41%

Volume12500.00

Market capHKD 377.47M

P/E (TTM)—

P/S (TTM)1.2x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.38

From 52W high

−59.41%

Volume

12500.00

Market cap

HKD 377.47M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.9x

P/E (TTM)

—

RSI (14)

51.2

MomentumView details →

1D Return

−2.82%

YTD Return

−25.81%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.9x

EV/Sales

1.1x

P/S (TTM)

1.2x

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

53.61%

Net Margin

−66.76%

EBITDA Margin

−38.17%

ROE (TTM)

−20.12%

ROA (TTM)

−13.06%

Asset Turnover

0.20x

GrowthView details →

Revenue YoY

−5.45%

EPS YoY

+25.58%

FCF YoY

+66.08%

Revenue CAGR 3Y

+18.30%

EPS CAGR 3Y

+5.75%

EBITDA YoY

+56.09%

MomentumView details →

1D Return

−2.82%

YTD Return

−25.81%

1Y Return

−56.74%

RSI (14)

51.2

vs 50D SMA

−0.07%

vs 200D SMA

−20.53%

Capital & dividendView details →

Debt/Equity

0.40x

Current Ratio

3.90x

Quick Ratio

3.32x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.30

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−HKD 0.46

Avg Surprise (4Q)

—

Rev Surprise

74.23%

Financials snapshotView financials →

Revenue (TTM)

260.68M

Net Income (TTM)

−174.03M

Op. CF (TTM)

−67.16M

Next earningsApr 1, 2027 →

Latest newsMore news →

China's National Medical Products Administration included CSPC Pharmaceutical Group's SYS 6010 in the breakthrough therapy designation list for recurrent or metastatic driver-gene-negative non-squamous non-small cell lung cancer that failed prior immunotherapy and platinum-based chemotherapy.5d ago

Basecare Medical (02170.HK) announced that its Gems series vitrification freezing solution set and vitrification thawing solution set recently each obtained Class III medical device registration certificates issued by China's National Medical Products Administration.5d ago

Similar companies

Austar Lifesciences Limited06118.HK Cryofocus Medtech (Shanghai) Co. Ltd.06922.HK Orthofix Medical Inc.OFIX AVITA Medical, Inc.RCEL Viemed Healthcare, Inc.VMD Broncus Holding Corporation02216.HK Find similar companies →

Latest newsMore news →

China's National Medical Products Administration included CSPC Pharmaceutical Group's SYS 6010 in the breakthrough therapy designation list for recurrent or metastatic driver-gene-negative non-squamous non-small cell lung cancer that failed prior immunotherapy and platinum-based chemotherapy.5d ago Basecare Medical (02170.HK) announced that its Gems series vitrification freezing solution set and vitrification thawing solution set recently each obtained Class III medical device registration certificates issued by China's National Medical Products Administration.5d ago